Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T‐cell lymphoblastic lymphoma
Authors:
- Julia Salmerón‐VillalobosJSJulia Salmerón‐Villalobos
- Joan Enric Ramis‐ZaldivarJRJoan Enric Ramis‐Zaldivar
- Olga BalaguéOBOlga Balagué
- Jaime Verdú‐AmorósJVJaime Verdú‐Amorós
- Constantino SábadoCSConstantino Sábado
- Sara MatoSMSara Mato
- Angela Gutierrez‐CaminoAGAngela Gutierrez‐Camino
- Daniel SinnettDSDaniel Sinnett
Open Access
- 24 August 2022
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 69 (11) , e29926
Abstract
Background: T‐cell lymphoblastic lymphoma (T‐LBL) is an aggressive neoplasm closely related to T‐cell acute lymphoblastic leukaemia (T‐ALL). Despite their similarities, and contrary to T‐ALL, studies on paediatric T‐LBL are scarce and, therefore, its molecular landscape has not yet been fully elucidated. Thus, the aims of this study were to characterize the genetic and molecular heterogeneity of paediatric T‐LBL and to evaluate novel molecular markers differentiating this entity from T‐ALL.Procedure: Thirty‐three paediatric T‐LBL patients were analyzed using an integrated approach, including targeted next‐generation sequencing, RNA‐sequencing transcriptome analysis and copy‐number arrays.Results: Copy number and mutational analyses allowed the detection of recurrent homozygous deletions of 9p/CDKN2A (78%), trisomy 20 (19%) and gains of 17q24‐q25 (16%), as well as frequent mutations of NOTCH1 (62%), followed by the BCL11B (23%), WT1 (19%) and FBXW7, PHF6 and RPL10 genes (15%, respectively). This genetic profile did not differ from that described in T‐ALL in terms of mutation incidence and global genomic complexity level, but unveiled virtually exclusive 17q25 gains and trisomy 20 in T‐LBL. Additionally, we identified novel gene fusions in paediatric T‐LBL, including NOTCH1–IKZF2, RNGTT–SNAP91 and DDX3X–MLLT10, the last being the only one previously described in T‐ALL. Moreover, clinical correlations highlighted the presence of Notch pathway alterations as a factor related to favourable outcome.Conclusions: In summary, the genomic landscape of paediatric T‐LBL is similar to that observed in T‐ALL, and Notch signaling pathway deregulation remains the cornerstone in its pathogenesis, including not only mutations but fusion genes targeting NOTCH1.Keywords
All Related Versions
This publication has 69 references indexed in Scilit:
- Clinical Impact of NOTCH1 and/or FBXW7 Mutations, FLASH Deletion, and TCR Status in Pediatric T-Cell Lymphoblastic LymphomaJournal of Clinical Oncology, 2012
- Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphomaHaematologica, 2011
- Predicting the functional impact of protein mutations: application to cancer genomicsNucleic Acids Research, 2011
- Notch signalling in T‐cell lymphoblastic leukaemia/lymphoma and other haematological malignanciesThe Journal of Pathology, 2010
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemiaBlood, 2009
- The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersProceedings of the National Academy of Sciences, 2009
- Requirement of Split ends for Epigenetic Regulation of Notch Signal-Dependent Genes during Infection-Induced Hemocyte DifferentiationMolecular and Cellular Biology, 2009
- WT1 Induction of Mitogen-Activated Protein Kinase Phosphatase 3 Represents a Novel Mechanism of Growth SuppressionMolecular Cancer Research, 2008
- BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytesBlood, 2006